Brief: Point Biopharma Confirms No Delays To Splash Trial Due To Recent Global Lutetium Supply Interruption

POINT Biopharma Global

22/03/2022 13:34

March 22 (Reuters) - POINT Biopharma Global Inc  PNT.O :
    * POINT BIOPHARMA CONFIRMS NO DELAYS TO SPLASH TRIAL DUE TO
RECENT
GLOBAL LUTETIUM SUPPLY INTERRUPTION
    * POINT BIOPHARMA - AFFIRMED REACTOR SHUTDOWN IN EUROPE,
CURRENT
EVENTS IN RUSSIA,UKRAINE HAVE NOT IMPACTED TRIAL TIMELINES/ 2022
OUTLOOK
    * POINT BIOPHARMA GLOBAL INC - CONTINUES TO EXPECT TO REPORT
TOP
LINE DATA FROM SPLASH MID-2023

Source text for Eikon:  ID:nGNX6jWfk7 
Further company coverage:  PNT.O 

 ((Reuters.Briefs@thomsonreuters.com;))